Blog – Europe PMC: Announcing the new version of SciLite – the Europe PMC tool for highlighting annotations

“This month, Europe PMC released a new version of SciLite, a powerful tool for highlighting annotations in life sciences publications. SciLite is powered by the Europe PMC annotation platform via the open annotation API, which provides access to over 1.3 billion annotations. Highlighting annotations in the text enables users to easily scan the article and locate key biological entities, such as genes/proteins, accession numbers, protein interactions, diseases, gene-disease relationship and more….”

Europe PMC: unlocking the potential of COVID-19 preprints | European Bioinformatics Institute

“Summary

Europe PMC is now indexing full-text preprints related to the COVID-19 pandemic and the SARS-CoV-2 virus, as well as the underlying data
The project will make COVID-19 scientific literature available as fast as possible in a single repository, in a format that allows text mining
Researchers and healthcare professionals will be able to access and reuse preprints more easily, accelerating research into better treatments or a vaccine….”

NIH Preprint Pilot in PubMed Central

“NLM is preparing to launch a pilot project to test the viability of making preprints resulting from NIH-funded research available via PubMed Central (PMC). The primary goal of the NIH Preprint Pilot will be to explore approaches to increasing the discoverability of early NIH research results. The pilot will begin the week of June 8, 2020 and will run for a minimum of 12 months. Lessons learned during that time will inform future NLM efforts with preprints.

In its role as the repository for peer-reviewed manuscripts supported by NIH, PMC already makes available more than one million published papers resulting from NIH-supported research. Building on NIH guidance (NOT-OD-17-050) to investigators that encouraged the use of interim research products, such as preprints, to speed the dissemination and enhance the rigor of their work, NLM hopes this pilot will inform possible future steps to further accelerate discovery and access of papers that are developed with NIH funds and encourage the open and fast dissemination of NIH research results, when appropriate.

The pilot will initially focus on increasing the discoverability of preprints with NIH support relating to the current COVID-19 pandemic. NLM is leveraging the iSearch COVID-19 portfolio tool developed by the NIH Office of Portfolio Analysis to identify preprints reporting on COVID-19 research supported by the NIH intramural or extramural programs. This narrowly scoped first phase should allow NLM an opportunity to streamline workflows and refine the details of implementation with a set of articles for which there is a growing demand for accelerated access.

As curation and ingest workflows become scalable, NLM will expand the pilot to include preprints resulting from the broader spectrum of NIH research….”

NIH Preprint Pilot in PubMed Central

“NLM is preparing to launch a pilot project to test the viability of making preprints resulting from NIH-funded research available via PubMed Central (PMC). The primary goal of the NIH Preprint Pilot will be to explore approaches to increasing the discoverability of early NIH research results. The pilot will begin the week of June 8, 2020 and will run for a minimum of 12 months. Lessons learned during that time will inform future NLM efforts with preprints.

In its role as the repository for peer-reviewed manuscripts supported by NIH, PMC already makes available more than one million published papers resulting from NIH-supported research. Building on NIH guidance (NOT-OD-17-050) to investigators that encouraged the use of interim research products, such as preprints, to speed the dissemination and enhance the rigor of their work, NLM hopes this pilot will inform possible future steps to further accelerate discovery and access of papers that are developed with NIH funds and encourage the open and fast dissemination of NIH research results, when appropriate.

The pilot will initially focus on increasing the discoverability of preprints with NIH support relating to the current COVID-19 pandemic. NLM is leveraging the iSearch COVID-19 portfolio tool developed by the NIH Office of Portfolio Analysis to identify preprints reporting on COVID-19 research supported by the NIH intramural or extramural programs. This narrowly scoped first phase should allow NLM an opportunity to streamline workflows and refine the details of implementation with a set of articles for which there is a growing demand for accelerated access.

As curation and ingest workflows become scalable, NLM will expand the pilot to include preprints resulting from the broader spectrum of NIH research….”

NIH Preprint Pilot in PubMed Central

“NLM is preparing to launch a pilot project to test the viability of making preprints resulting from NIH-funded research available via PubMed Central (PMC). The primary goal of the NIH Preprint Pilot will be to explore approaches to increasing the discoverability of early NIH research results. The pilot will begin the week of June 8, 2020 and will run for a minimum of 12 months. Lessons learned during that time will inform future NLM efforts with preprints.

In its role as the repository for peer-reviewed manuscripts supported by NIH, PMC already makes available more than one million published papers resulting from NIH-supported research. Building on NIH guidance (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-050.html) to investigators that encouraged the use of interim research products, such as preprints, to speed the dissemination and enhance the rigor of their work, NLM hopes this pilot will inform possible future steps to further accelerate discovery and access of papers that are developed with NIH funds and encourage the open and fast dissemination of NIH research results, when appropriate.

The pilot will initially focus on increasing the discoverability of preprints with NIH support relating to the current COVID-19 pandemic. NLM is leveraging the iSearch COVID-19 portfolio tool (https://icite.od.nih.gov/covid19/search/) developed by the NIH Office of Portfolio Analysis to identify preprints reporting on COVID-19 research supported by the NIH intramural or extramural programs. This narrowly scoped first phase should allow NLM an opportunity to streamline workflows and refine the details of implementation with a set of articles for which there is a growing demand for accelerated access.

As curation and ingest workflows become scalable, NLM will expand the pilot to include preprints resulting from the broader spectrum of NIH research. Further, to enable NIH investigators to more easily report preprints as products of award, NLM will simplify the process for adding preprint citations to My Bibliography this summer.

NLM expects to engage with preprint servers throughout the pilot that include a significant volume of preprints with NIH support and meet the general expectations laid out in the 2017 NIH Guidance for selecting interim research product repositories.”

NIH Preprint Pilot in PubMed Central

“NLM is preparing to launch a pilot project to test the viability of making preprints resulting from NIH-funded research available via PubMed Central (PMC). The primary goal of the NIH Preprint Pilot will be to explore approaches to increasing the discoverability of early NIH research results. The pilot will begin the week of June 8, 2020 and will run for a minimum of 12 months. Lessons learned during that time will inform future NLM efforts with preprints.

In its role as the repository for peer-reviewed manuscripts supported by NIH, PMC already makes available more than one million published papers resulting from NIH-supported research. Building on NIH guidance (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-050.html) to investigators that encouraged the use of interim research products, such as preprints, to speed the dissemination and enhance the rigor of their work, NLM hopes this pilot will inform possible future steps to further accelerate discovery and access of papers that are developed with NIH funds and encourage the open and fast dissemination of NIH research results, when appropriate.

The pilot will initially focus on increasing the discoverability of preprints with NIH support relating to the current COVID-19 pandemic. NLM is leveraging the iSearch COVID-19 portfolio tool (https://icite.od.nih.gov/covid19/search/) developed by the NIH Office of Portfolio Analysis to identify preprints reporting on COVID-19 research supported by the NIH intramural or extramural programs. This narrowly scoped first phase should allow NLM an opportunity to streamline workflows and refine the details of implementation with a set of articles for which there is a growing demand for accelerated access.

As curation and ingest workflows become scalable, NLM will expand the pilot to include preprints resulting from the broader spectrum of NIH research. Further, to enable NIH investigators to more easily report preprints as products of award, NLM will simplify the process for adding preprint citations to My Bibliography this summer.

NLM expects to engage with preprint servers throughout the pilot that include a significant volume of preprints with NIH support and meet the general expectations laid out in the 2017 NIH Guidance for selecting interim research product repositories.”

PubMed Central archiving: a major milestone for a scholarly journal

“There are concerns that authors in developing countries and those lacking research funds are disadvantaged by Plan S and cut out of quality gold open-access journals.3 The latter, however, is largely compensated by the availability of platinum open-access journals, such as the MJR, where publishing and archiving charges are covered by professional societies, easing the authors’ and readers’ financial burden.4…”

Navigating the NIH Public Access Policy for Peer-Reviewed Manuscripts – Why and How to get a PMCID Number

“Manuscripts are required to be publicly available no later than 12 months following original publication date depending on the embargo period of the publisher; however, manuscripts are non-compliant if the PubMed Central Identification (PMCID) number has not been acquired 90 days after the original publication date. Steps to acquire a PMCID are provided below. Embargo periods for each journal in PMC can be found in the “Free Access” column on the PMC Journal List. The exact release date for each article under embargo is displayed in PMC search results, on the table of contents for the issue, or in the corresponding PubMed record. To obtain access to an article prior to its availability in PMC, individuals must contact the respective journal publisher directly….”

Elsevier gives full access to its content on its COVID-19 Information Center for PubMed Central and other public health databases to accelerate fight against coronavirus

“From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health’s National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing. This additional access allows researchers to use artificial intelligence to keep up with the rapidly growing body of literature and identify trends as countries around the world address this global health crisis.

In January, Elsevier created the COVID-19 Information Center with free information in English and Mandarin on the novel coronavirus. The Information Center is updated daily with the latest research information on the virus and the disease and includes links to more than 19,500 freely available articles on ScienceDirect, Elsevier’s platform of peer-reviewed scholarly literature. Since its launch, the Information Center has been visited by more than a quarter of a million scientists, researchers, clinicians and others, 15 percent of whom are in the US….”

Elsevier gives full access to its content on its COVID-19 Information Center for PubMed Central and other public health databases to accelerate fight against coronavirus

“From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health’s National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing. This additional access allows researchers to use artificial intelligence to keep up with the rapidly growing body of literature and identify trends as countries around the world address this global health crisis.

In January, Elsevier created the COVID-19 Information Center with free information in English and Mandarin on the novel coronavirus. The Information Center is updated daily with the latest research information on the virus and the disease and includes links to more than 19,500 freely available articles on ScienceDirect, Elsevier’s platform of peer-reviewed scholarly literature. Since its launch, the Information Center has been visited by more than a quarter of a million scientists, researchers, clinicians and others, 15 percent of whom are in the US….”